Latest Articles
KU Cancer Center evaluating progestin use to treat endometrial cancer - University of Kansas Medical Center
KU Cancer Center evaluating progestin use to treat endometrial cancer University of Kansas Medical Center
Published: Sept. 25, 2025, 8:16 p.m.
Long COVID associated with abnormal uterine bleeding and cycle-phase symptom variation - Medical Xpress
Long COVID associated with abnormal uterine bleeding and cycle-phase symptom variation Medical Xpress
Published: Sept. 21, 2025, 11:20 a.m.
Lori Harvey Opens Up About PCOS, Endometriosis, And Medical Bias Against Black Women - NewsBreak: Local News & Alerts
Lori Harvey Opens Up About PCOS, Endometriosis, And Medical Bias Against Black Women NewsBreak: Local News & Alerts
Published: Sept. 18, 2025, 11:22 p.m.
Lori Harvey Opens Up About PCOS, Endometriosis, And Medical Bias Against Black Women - Black Enterprise
Lori Harvey Opens Up About PCOS, Endometriosis, And Medical Bias Against Black Women Black Enterprise
Published: Sept. 18, 2025, 10:41 p.m.
Lori Harvey’s Medical Diagnosis … Which Causes Her To Grow Facial Hair! - mediatakeout.com
Lori Harvey’s Medical Diagnosis … Which Causes Her To Grow Facial Hair! mediatakeout.com
Published: Sept. 16, 2025, 3:25 p.m.
Medical experts caution: One overlooked sign could require urgent medical attention - Metabolic - OkDiario
Medical experts caution: One overlooked sign could require urgent medical attention - Metabolic OkDiario
Published: Sept. 15, 2025, 11 a.m.
Q&A with Daniel Powell, President & CEO at Spark Biomedical - citybiz
Q&A with Daniel Powell, President & CEO at Spark Biomedical citybiz
Published: Sept. 11, 2025, 7:23 p.m.
Australia a world leader in endo - Medical Republic
Australia a world leader in endo Medical Republic
Published: Sept. 10, 2025, 6:02 a.m.
New radiotheranostic targets identified for diagnosis and treatment of endometrial cancer - Medical Xpress
New radiotheranostic targets identified for diagnosis and treatment of endometrial cancer Medical Xpress
Published: Sept. 5, 2025, 4:10 p.m.
HER2 and CD24 emerge as promising radiotheranostic targets in endometrial cancer - News-Medical
HER2 and CD24 emerge as promising radiotheranostic targets in endometrial cancer News-Medical
Published: Sept. 5, 2025, 4 a.m.
Link copied to clipboard!